Physician
ST Vincents Pathology Associates PA
ST Vincents Pathology Associates PA was paid $1.44M by Medicaid between Jan 2018 and Dec 2024, across 104 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 21% of everything it billed.
33Billing provider infoST VINCENTS PATHOLOGY ASSOCIATES PA
JACKSONVILLE, FL 32204
JACKSONVILLE, FL 32204
33aNPI1114074200assigned 01/04/2007
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$1.44M
24GClaims663,894
24DCodes billed104
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#14 of 207
Median peer was paid$39K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,727 | $3K | |
| 2019 | 70,862 | $165K | |
| 2020 | 90,920 | $242K | |
| 2021 | 126,989 | $282K | |
| 2022 | 169,467 | $226K | |
| 2023 | 130,171 | $361K | |
| 2024incomplete | 71,758 | $156K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 21% | 7,363 | 6,087 | $295K |
| 80053 | Comprehensive metabolic panel | 12% | 56,240 | 39,954 | $170K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 11% | 15,176 | 12,386 | $163K |
| 88307 | 9.0% | 3,063 | 2,694 | $129K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.8% | 18,798 | 15,226 | $83K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.5% | 46,280 | 20,449 | $65K |
| 87040 | 3.8% | 6,977 | 5,085 | $54K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.7% | 97,512 | 53,124 | $54K |
| 84484 | 3.3% | 27,904 | 18,926 | $48K | |
| 83880 | 2.2% | 3,146 | 2,400 | $32K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 7,924 | 6,833 | $29K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 1,943 | 1,799 | $27K |
92 more codes
| 82803 | 1.9% | 6,108 | $27K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.5% | 5,582 | $21K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.3% | 3,615 | $19K |
| 81025 | 1.0% | 17,874 | $15K | |
| 87400 | <1% | 2,262 | $12K | |
| 83735 | <1% | 28,036 | $12K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,634 | $11K |
| 85060 | <1% | 957 | $11K | |
| 86850 | <1% | 15,235 | $9K | |
| 86900 | <1% | 20,517 | $9K | |
| 87634 | <1% | 1,071 | $8K | |
| 83605 | <1% | 11,503 | $8K | |
| 85027 | <1% | 12,200 | $8K | |
| 81001 | <1% | 31,179 | $7K | |
| 83690 | <1% | 16,231 | $7K | |
| 84702 | <1% | 4,504 | $6K | |
| 84703 | <1% | 13,893 | $6K | |
| 87186 | <1% | 3,098 | $6K | |
| 87641 | <1% | 1,279 | $6K | |
| 85730 | <1% | 9,785 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,993 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,818 | $4K |
| 86901 | <1% | 19,359 | $4K | |
| 80061 | Lipid panel | <1% | 3,592 | $4K |
| 80047 | <1% | 1,172 | $4K | |
| 88342 | <1% | 369 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,994 | $3K |
| 85610 | <1% | 11,673 | $3K | |
| 87077 | <1% | 2,543 | $2K | |
| 86592 | <1% | 8,734 | $2K | |
| 87430 | <1% | 1,603 | $2K | |
| 84100 | <1% | 9,228 | $2K | |
| 81003 | <1% | 12,595 | $2K | |
| 87210 | <1% | 3,891 | $2K | |
| 80076 | <1% | 4,163 | $2K | |
| 87070 | <1% | 2,266 | $2K | |
| 85018 | <1% | 9,815 | $1K | |
| 86880 | <1% | 935 | $1K | |
| 84112 | <1% | 163 | $1K | |
| 85379 | <1% | 2,867 | $1K | |
| 82570 | <1% | 3,265 | $1K | |
| 83615 | <1% | 3,338 | $1K | |
| 82607 | <1% | 1,124 | $1K | |
| 84550 | <1% | 3,636 | $1K | |
| 87205 | <1% | 3,551 | $990.60 | |
| 80329 | <1% | 1,748 | $960.55 | |
| 84145 | <1% | 1,710 | $960.30 | |
| 86140 | <1% | 3,358 | $869.72 | |
| 82746 | <1% | 780 | $754.43 | |
| 84156 | <1% | 3,052 | $733.23 | |
| 82550 | <1% | 1,835 | $730.84 | |
| 85014 | <1% | 5,745 | $651.31 | |
| 84466 | <1% | 598 | $587.86 | |
| 80202 | <1% | 563 | $571.48 | |
| 86923 | <1% | 478 | $571.44 | |
| 82248 | <1% | 1,119 | $567.37 | |
| 84439 | <1% | 1,079 | $556.00 | |
| 82728 | <1% | 666 | $549.34 | |
| 86803 | <1% | 161 | $544.43 | |
| 87081 | <1% | 1,622 | $530.40 | |
| 84132 | <1% | 2,325 | $482.43 | |
| 86703 | <1% | 520 | $419.95 | |
| 82140 | <1% | 584 | $345.44 | |
| 87807 | <1% | 335 | $319.31 | |
| 80320 | <1% | 943 | $316.75 | |
| 82731 | <1% | 29 | $315.74 | |
| 82565 | <1% | 1,051 | $308.73 | |
| 85049 | <1% | 321 | $264.86 | |
| 82247 | <1% | 509 | $230.36 | |
| 87147 | <1% | 96 | $228.16 | |
| 83540 | <1% | 550 | $198.02 | |
| 82010 | <1% | 536 | $194.96 | |
| 85652 | <1% | 1,124 | $185.29 | |
| 87015 | <1% | 305 | $147.15 | |
| 84450 | <1% | 333 | $137.38 | |
| 84460 | <1% | 338 | $123.79 | |
| 87075 | <1% | 160 | $111.84 | |
| 80074 | <1% | 15 | $107.85 | |
| 82330 | <1% | 136 | $101.79 | |
| 86870 | <1% | 26 | $90.35 | |
| 84134 | <1% | 112 | $89.10 | |
| 80069 | <1% | 210 | $74.10 | |
| 85045 | <1% | 305 | $69.07 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 174 | $30.00 |
| 87340 | <1% | 38 | $23.18 | |
| 82376 | <1% | 42 | $21.14 | |
| 85461 | <1% | 30 | $12.20 | |
| 83045 | <1% | 42 | $10.52 | |
| 82077 | <1% | 1,163 | $10.00 | |
| 85384 | <1% | 26 | $5.20 | |
| 82947 | <1% | 34 | $1.71 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 392 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDESTEPHANO, DON (PRESIDENT)